Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1682639 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.34Day −3.31%Mkt cap $35M1Y −73.3%Off 52W high −84.4%Vol (1Y) 135.5%
Daily closing price, split-adjusted to the current basis; 1y shown of 259 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.1% of sh out |
| Days to cover5.2d |
| 13F net flow (QoQ)+1.58% |
| Top-10 13F concentration84.8% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$813,455 |
| Earnings (TTM)-$33.0M |
| Net margin−5570.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−34.3% |
| 1Y−73.3% |
| Since incept. (ann.)−81.6% |
Total return through 2026-07-29 · series begins 2025-07-03. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)135.5% |
| Ann. volatility (3Y)142.0% |
| Sharpe (1Y)−0.41 |
| Sharpe (3Y)−0.55 |
| Max drawdown (1Y)−84.4% |
| Max drawdown (3Y)−85.3% |
| Beta (3Y vs SPY)1.63 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| MORGAN STANLEY | 237,986 | $821,051 | 1.57% | +56698.6% |
| Redwood Wealth Management Group, LLC | 183,273 | $632,292 | 1.21% | +2.1% |
| JANE STREET GROUP, LLC | 128,280 | $442,566 | 0.85% | −7.3% |
| RENAISSANCE TECHNOLOGIES LLC | 115,641 | $398,961 | 0.76% | −37.9% |
| CITADEL ADVISORS LLC | 112,906 | $389,526 | 0.74% | +563.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 84,409 | $291,211 | 0.56% | new |
| BlackRock, Inc. | 81,108 | $279,823 | 0.54% | +3.8% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,080 | $265,975 | 0.51% | +28.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | $0.26 | — | $244,271 | +1559.4% |
| 2025-09-30 | 2025-11-13 | $0.05 | — | $302,506 | +18515.8% |
| 2025-06-30 | 2025-08-13 | −$2.50 | — | — | — |
| 2025-03-31 | 2025-05-19 | −$1.59 | — | $14,720 | +194.8% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
